These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 17487652

  • 1. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
    Lundström E, Bygdeson M, Svane G, Azavedo E, von Schoultz B.
    Climacteric; 2007 Jun; 10(3):249-56. PubMed ID: 17487652
    [Abstract] [Full Text] [Related]

  • 2. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
    Lundström E, Hirschberg AL, Söderqvist G.
    Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB, Manassiev NA.
    Medscape Womens Health; 2002 Dec; 7(4):1. PubMed ID: 12466733
    [Abstract] [Full Text] [Related]

  • 4. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
    Stuedal A, Ma H, Bjørndal H, Ursin G.
    Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
    [Abstract] [Full Text] [Related]

  • 5. The effect of low dose hormone therapy on mammographic breast density.
    Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Vlachou S, Creatsa M, Panoulis KP, Botsis D.
    Maturitas; 2006 Apr 20; 54(1):78-85. PubMed ID: 16198519
    [Abstract] [Full Text] [Related]

  • 6. Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.
    Panoulis C, Lambrinoudaki I, Vourtsi A, Augoulea A, Kaparos G, Aravantinos L, Christodoulakos G, Creatsas G.
    Climacteric; 2009 Jun 20; 12(3):240-7. PubMed ID: 19387881
    [Abstract] [Full Text] [Related]

  • 7. Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
    Samsioe G, Hruska J, CHOICE Study Investigators.
    Climacteric; 2010 Feb 20; 13(1):34-44. PubMed ID: 20001563
    [Abstract] [Full Text] [Related]

  • 8. Testosterone addition during menopausal hormone therapy: effects on mammographic breast density.
    Hofling M, Lundström E, Azavedo E, Svane G, Hirschberg AL, von Schoultz B.
    Climacteric; 2007 Apr 20; 10(2):155-63. PubMed ID: 17453864
    [Abstract] [Full Text] [Related]

  • 9. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M, Carlström K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B.
    Gynecol Endocrinol; 2005 Feb 20; 20(2):110-5. PubMed ID: 15823831
    [Abstract] [Full Text] [Related]

  • 10. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
    Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM.
    BJOG; 2008 May 20; 115(6):773-9. PubMed ID: 18355366
    [Abstract] [Full Text] [Related]

  • 11. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O, Lim P, Caubel P.
    Clin Ther; 2000 May 20; 22(5):622-36. PubMed ID: 10868559
    [Abstract] [Full Text] [Related]

  • 12. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E, Holinka CF, Arrenbrecht S.
    Int J Fertil Womens Med; 1997 May 20; 42 Suppl 2():388-98. PubMed ID: 9397386
    [Abstract] [Full Text] [Related]

  • 13. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women.
    Grady D, Vittinghoff E, Lin F, Hanes V, Ensrud K, Habel LA, Wallace R, Macer J, Cummings SR, Shepherd J.
    Menopause; 2007 May 20; 14(3 Pt 1):391-6. PubMed ID: 17224859
    [Abstract] [Full Text] [Related]

  • 14. Influence of different HRT regimens on mammographic density.
    Junkermann H, von Holst T, Lang E, Rakov V.
    Maturitas; 2005 Feb 14; 50(2):105-10. PubMed ID: 15653007
    [Abstract] [Full Text] [Related]

  • 15. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H, Odabaşi AR, Demircan S, Karul A, Kozaci LD, Köseoğlu K, Kizilkaya K, Başak O.
    Gynecol Endocrinol; 2006 Jul 14; 22(7):381-7. PubMed ID: 16864148
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
    Climacteric; 2001 Dec 14; 4(4):320-31. PubMed ID: 11770189
    [Abstract] [Full Text] [Related]

  • 17. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW, Gluck OS, Lang E, Rakov V.
    Menopause; 2005 Dec 14; 12(6):741-8. PubMed ID: 16278618
    [Abstract] [Full Text] [Related]

  • 18. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M.
    Maturitas; 2004 Jun 15; 48(2):137-46. PubMed ID: 15172088
    [Abstract] [Full Text] [Related]

  • 19. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR.
    Maturitas; 2008 Jan 20; 59(1):2-6. PubMed ID: 18063490
    [Abstract] [Full Text] [Related]

  • 20. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C, Palacios S, Vázquez F, Villero J, Ferrer J, Ascaso C, Balasch J.
    Fertil Steril; 2007 Aug 20; 88(2):383-9. PubMed ID: 17561009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.